Search research articles
Contact Us
Filters
Showing results (11-20 of 376) with videos related to
Page
of 38
Sort By:
Fundamental & Clinical Pharmacology
|
September 8, 2011
Clinical effects and outcomes with new P2Y12 inhibitors in ACS
Jean-Philippe Collet, Stephen O'Connor
European Heart Journal
|
November 18, 2020
Prasugrel over ticagrelor in non-ST-elevation acute coronary syndromes: is it justified?
Jean-Philippe Collet, Holger Thiele
Presse Medicale (Paris, France : 1983)
|
December 15, 2018
[Aortic stenosis in the elderly: The TAVI revolution]
Pavel Overtchouk, Jean-Philippe Collet
European Heart Journal
|
October 21, 2020
The 'Ten Commandments' for the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet, Holger Thiele
Thrombosis and Haemostasis
|
January 28, 2021
Antithrombotic Therapy in Acute Coronary Syndromes: Current Evidence and Ongoing Issues Regarding Early and Late Management
Paul Guedeney, Jean-Philippe Collet
JACC. Cardiovascular Interventions
|
June 20, 2020
Vascular Access Site for TAVR: Use the Approach You Master Best
Jules Mesnier, Jean Philippe Collet
European Heart Journal
|
April 16, 2013
Any room left for new antiplatelet agents in acute coronary syndrome?
Jean-Philippe Collet, Gilles Montalescot
JACC. Cardiovascular Interventions
|
August 9, 2020
Would Anyone Dare Abandon Repositioning of Self-Expanding TAVR?
Olivier Barthélémy, Jean-Philippe Collet
European Heart Journal
|
November 13, 2020
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation - Dual versus triple antithrombotic therapy
Jean-Philippe Collet, Holger Thiele
Journal of Clinical Medicine
|
October 31, 2020
Diagnosis and Management of Acute Coronary Syndrome: What is New and Why? Insight From the 2020 European Society of Cardiology Guidelines
Paul Guedeney, Jean-Philippe Collet
Page
of 38
Search research articles
Search
Showing results (11-20 of 376) with videos related to
Sort By:
Page
of 38
Fundamental & Clinical Pharmacology
|
September 8, 2011
Clinical effects and outcomes with new P2Y12 inhibitors in ACS
Jean-Philippe Collet, Stephen O'Connor
European Heart Journal
|
November 18, 2020
Prasugrel over ticagrelor in non-ST-elevation acute coronary syndromes: is it justified?
Jean-Philippe Collet, Holger Thiele
Presse Medicale (Paris, France : 1983)
|
December 15, 2018
[Aortic stenosis in the elderly: The TAVI revolution]
Pavel Overtchouk, Jean-Philippe Collet
European Heart Journal
|
October 21, 2020
The 'Ten Commandments' for the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet, Holger Thiele
Thrombosis and Haemostasis
|
January 28, 2021
Antithrombotic Therapy in Acute Coronary Syndromes: Current Evidence and Ongoing Issues Regarding Early and Late Management
Paul Guedeney, Jean-Philippe Collet
JACC. Cardiovascular Interventions
|
June 20, 2020
Vascular Access Site for TAVR: Use the Approach You Master Best
Jules Mesnier, Jean Philippe Collet
European Heart Journal
|
April 16, 2013
Any room left for new antiplatelet agents in acute coronary syndrome?
Jean-Philippe Collet, Gilles Montalescot
JACC. Cardiovascular Interventions
|
August 9, 2020
Would Anyone Dare Abandon Repositioning of Self-Expanding TAVR?
Olivier Barthélémy, Jean-Philippe Collet
European Heart Journal
|
November 13, 2020
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation - Dual versus triple antithrombotic therapy
Jean-Philippe Collet, Holger Thiele
Journal of Clinical Medicine
|
October 31, 2020
Diagnosis and Management of Acute Coronary Syndrome: What is New and Why? Insight From the 2020 European Society of Cardiology Guidelines
Paul Guedeney, Jean-Philippe Collet
Page
of 38